ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ZetrOZ Systems to Attend and Present at the Big Sky Athletic Training Sports Medicine Conference

The conference provides continuing education and facilitates communication among interested sports medicine professionals.

ZetrOZ Systems
ZetrOZ Systems

ZetrOZ Systems

ZetrOZ Systems will present new research on its sam® ultrasound device at the Big Sky Athletic Training Sports Medicine Conference in Big Sky, Montana, from Jan. 29 to Feb. 2. The program brings together athletic trainers and professionals across various disciplines of sports medicine in support of improving patient care.

Founder and CEO of ZetrOZ, Dr. George Lewis, will present on Combined Multicenter Randomized Placebo-Controlled Studies of Long Duration Continuous Ultrasound for Soft Tissue Pathology on Monday, Jan. 30, at 3:20 p.m. Mountain Standard Time.

The first evening will conclude with an NFL Playoff Welcome Reception co-hosted by ZetrOZ and DJO Orthopedics. Family and friends are invited to attend the reception, which will take place at 6 p.m. in the Jefferson Room at Big Sky Resort's Yellowstone Conference center.

"We are fortunate to have the opportunity to present at this year's conference," said Dr. Lewis. "It's an excellent opportunity for us to exchange ideas and share the benefits of sam® with a community of professionals dedicated to improving the health and performance of athletes."

The FDA has cleared ZetrOZ Systems' sam® as the only long-duration ultrasound device for prescription home use. The device uses multi-hour ultrasound to generate deep diathermy in tissue and is clinically proven to reduce chronic joint and back pain in multiple clinical trials. 

Meta-analyses demonstrate the device's unique ultrasound treatment algorithm is safe, effective, and a clinically valid treatment option for joint arthritis, upper neck, shoulder, and back pain, and the treatment of soft-tissue injuries. Additional studies report that daily sam® treatment reduced tendon pain by 90% in patients with chronic tendinopathy and arthritis pain by 40% in patients with moderate to severe knee osteoarthritis.

Registration is free of charge for sponsors, speakers, poster presenters, and students. Tickets are $150 for non-student attendees; a financial hardship option is available for $100. To register for the conference, visit https://bsatsmc.org/registration

To learn more, visit zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents. The exclusive manufacturer and developer of the sam® product line is designed for the treatment of acute and chronic musculoskeletal conditions.

Contact Information:
Buse Kayar
buse@newswire.com


Original Source: ZetrOZ Systems to Attend and Present at the Big Sky Athletic Training Sports Medicine Conference
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.